INTRODUCTION “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021,” Pfizer’s post-marketing report, a required U.S. Food and Drug Administration (FDA) compliance document, is one of the ways in which the FDA assessed patients’ risks associated with Pfizer’s COVID-19 vaccine, BNT162b2. The data within the Pfizer’s 5.3.6 analysis are not […]
Walking Among Sequoias
Although I have never had the opportunity to visit the forests where sequoias grow, it would no doubt be spectacular. I do feel, recently, that I have come very close to such an experience through being a member of the WarRoom/DailyClout Pfizer Documents Analysis Project. My fellow volunteers on this project stand tall, strong, […]